Skip to main content
. 2024 Mar 8;15:1332757. doi: 10.3389/fimmu.2024.1332757

Table 3.

Casual effects of MR Analysis between GM and T1DN/T2DN (P value corrected by FDR).

Outcome Level Exposure Method NO.SNP P PFDR
T1DN genus Eubacteriumcoprostanoligenesgroup IVW 13 0.000783 0.002125763
MR Egger 0.120655 0.327492218
WM 0.002616 0.007100466
T2DN family Verrucomicrobiaceae IVW 11 0.002196 0.008343025
MR Egger 0.709418 2.695786857
WM 0.084151 0.319773891
order Verrucomicrobiales IVW 11 0.002187 0.002444585
MR Egger 0.706851 0.790009472
WM 0.090536 0.101187786
Rhodospirillales IVW 11 0.002196 0.002607195
MR Egger 0.082865 0.842433393
WM 0.709418 0.098402182
class Verrucomicrobiae IVW 11 0.002187 0.013852647
MR Egger 0.706851 4.47672034
WM 0.075537 0.478403913
phylum Proteobacteria IVW 12 0.002858 0.002857644
MR Egger 0.697337 0.697336558
WM 0.047523 0.047522824

No. SNP is the number of SNPs being used as IVs; Significant P was marked in bold; MR, Mendelian randomization; SNP, single-nucleotide polymorphism; IV, instrumental variable; IVW, inverse-variance weighted; WM, weighted median; OR, odds ratio; CI, confidence interval; PFDR, P value corrected by false discovery rate (FDR). SNP: single nucleotide polymorphism; T2DN, type 2 diabetic nephropathy; T1DN, type 1 diabetic nephropathy. The bold values refer to the P-values still less than 0.05 after FDR correction.